๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum-based ALYGNSA immunoassay for the prostate cancer biomarker, total prostate-specific antigen (tPSA)

โœ Scribed by Brian C. Mackness; Melisenda J. McDonald

Book ID
105893346
Publisher
Springer
Year
2010
Tongue
English
Weight
124 KB
Volume
397
Category
Article
ISSN
1618-2650

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Development of simultaneous detection of
Development of simultaneous detection of total prostate-specific antigen (tPSA) and free PSA with rapid bead-based immunoassay
โœ Chong Xie; Guomin Wang ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB

Objective: Prostate-specific antigen (PSA) is the most important biochemical tumor marker for the early detection of prostate cancer; however, its diagnostic specificity is low. Therefore, free PSA (fPSA) test is recommended as an adjunct to increase the specificity. However, all the current technol

The fall and rise of prostate-specific a
The fall and rise of prostate-specific antigen: Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer
โœ Gunar K. Zagars; Alan Pollack ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 890 KB

Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O